
1. rinsho ketsueki. 2019;60(9):1331-1336. doi: 10.11406/rinketsu.60.1331.

[hematopoietic cell transplantation chronic active ebv infection].

[article japanese]

inoue m(1).

author information: 
(1)department hematology/oncology, osaka women's children's hospital.

chronic active ebv infection (caebv) one ebv-associated t/nk
lymphoproliferative diseases. prognosis caebv poor, without
curative therapy, almost half patients die within five years onset.
the results 3-step treatment regimen consisting step 1
(immunochemotherapy), step 2 (multi-drug chemotherapy), step 3 (hematopoietic
cell transplantation, hct) excellent. hct cure caebv, and
reduced-intensity conditioning (ric) superior myeloablative conditioning
(mac). overall survival rate typically 90% following bone marrow
transplantation cord blood transplantation.

doi: 10.11406/rinketsu.60.1331 
pmid: 31597860  [indexed medline]

